Serotonin dysfunction and suicide attempts in major depressives: An auditory event-related potential study

Neuropsychobiology

Volumn 52, Issue 1, 2005, Pages 28-36

  Chen, Tai Jui ^a,b,c   Yu, Younger W Y ^d   Chen, Ming Chao ^a   Wang, Shing Yaw ^a   Tsai, Shih Jen ^e,f   Lee, Tien Wen ^g,h  

^a KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

^d Yu's Psychiatric Clinic   (Taiwan)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^h NONE   (United Kingdom)

Author keywords

Event related potential; Loudness dependent auditory evoked potential; Major depression; P300; Suicide attempt

Indexed keywords

SEROTONIN;

ADULT; AMPLITUDE MODULATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVOKED AUDITORY RESPONSE; GENDER; HUMAN; LOUDNESS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SUICIDE ATTEMPT; VALIDATION PROCESS;

ADULT; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LINEAR MODELS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SUICIDE, ATTEMPTED;

EID: 21344439810     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086175     Document Type: Article

References (43)

1. Bachus SE, Hyde TM, Akil M, Weickert CS, Vawter MP, Kleinman JE: Neuropathology of suicide. A review and an approach. Ann N Y Acad Sci 1997;836:201-219.
2. Engstrom G, Ailing C, Blennow K, Regnell G, Traskman-Bendz L: Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol 1999;9:399-405.
3. Gross-Isseroff R, Biegon A, Voet H, Weizman A: The suicide brain: A review of postmortem receptor/transporter binding studies. Neurosci Biobehav Rev 1998;22:653-661.
4. Maris RW: Suicide. Lancet 2002;360:319-326.
5. Tripodianakis J, Markianos M, Sarantidis D, Leotsakou C: Neurochemical variables in subjects with adjustment disorder after suicide attempts. Eur Psychiatry 2000;15:190-195.
6. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ: Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001;25:892-903.
7. Malone KM, Corbitt EM, Li S, Mann JJ: Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996;168:324-329.
8. Mann JJ, Malone KM: Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 1997;41:162-171.
9. Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ: Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 2003;60:14-22.
10. van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, Dierckx RA: Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord 2003;74:149-158.
11. Keilp JG, Sackeim HA, Brodsky BS, Oquendo MA, Malone KM, Mann JJ: Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001;158:735-741.
12. Hegerl U, Gallint J, Mrowinski D: Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 1994;17:1-13.
13. Hegerl U, Gallinat J, Juckel G: Event-related potentials: Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 2001;62:93-100.
14. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G: Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 1997;41:1181-1195.
15. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G: Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 1999;21:710-716.
16. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U: The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology 2000;148:404-411.
17. Juckel G, Hegerl U: Evoked potentials, serotonin, and suicidality. Pharmacopsychiatry 1994;27(suppl 1):27-29.
18. Vandoolaeghe E, van Hunsel F, Nuyten D, Maes M: Auditory event related potentials in major depression: Prolonged P300 latency and increased P200 amplitude. J Affect Disord 1998;48:105-113.
19. Kim MS, Kim JJ, Kwon JS: Frontal P300 decrement and executive dysfunction in adolescents with conduct problems. Child Psychiatry Hum Dev 2001;32:93-106.
20. Knight RT, Scabini D: Anatomic bases of event related potentials and their relationship to novelty detection in humans. J Clin Neurophysiol 1998;15:3-13.
21. Nieman DH, Koelman JH, Linszen DH, Bour LJ, Dingemans PM, Ongerboer de Visser BW: Clinical and neuropsychological correlates of the P300 in schizophrenia. Schizophr Res 2002;55:105-113.
22. Hansenne M, Pitchot W, Gonzalez Moreno A, Gonzalez Torrecilas J, Mirel J, Ansseau M: Psychophysiological correlates of suicidal behavior in depression. A preliminary study. Neuropsychobiology 1994;30:1-3.
23. Hansenne M, Pitchot W, Gonzalez Moreno A, Zaldua IU, Ansseau M: Suicidal behavior in depressive disorder: An event-related potential study. Biol Psychiatry 1996;40:116-122.
24. Pierson A, Ragot R, Martinerie J, Partiot A, Renault B, Jouvent R: Heterogeneity of information-processing alterations according to dimensions of depression: An event-related potentials study. Biol Psychiatry 1996;40:98-115.
25. Baca-Garcia E, Diaz-Sastre C, Basurte E, Prieto R, Ceverino A, Saiz-Ruiz J, de Leon J: A prospective study of the paradoxical relationship between impulsivity and lethality of suicide attempts. J Clin Psychiatry 2001;62:560-564.
26. d'Ardhuy XL, Boeijinga PH, Renault B, Luthringer R, Rinaudo G, Soufflet L, Toussaint M, Macher J: Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential. Neuropsychobiology 1999;40:207-213.
27. Hansenne M, Ansseau M: P300 event-related potential and serotonin-1A activity in depression. Eur Psychiatry 1999;14:143-147.
28. Hasbroucq T, Rihet P, Blin O, Possamai CA: Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neurosci Lett 1997;229:204-208.
29. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Press, 1994.
30. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
31. Carrillo-de-la-Peña MT, Mavrogiorgou P, Juckel G, Hauke W, Gallinat J, Frodl T, Zaudig M, Hegerl U: Loudness dependence of auditory evoked potentials in obsessive-compulsive disorder: a pilot study. Psychiatry Res 2000;93:209-216.
32. Lin CH, Yu YWY, Chen TJ, Tsai SJ, Hong CJ: Association analysis for dopamine D2 receptor Taq1 polymorphism with P300 event-related potential for normal young females. Psychiatr Genet 2001;11:165-168.
33. Chen TJ, Yu YWY, Chen MC, Tsai SJ, Hong CJ: Association analysis for serotonin transporter promoter polymorphism and auditory evoked potentials for major depression. Neuropsychobiology 2002;46:57-60.
34. Wang W, Wang YH, Fu XM, Sun ZM, Schoenen J: Auditory evoked potentials and multiple personality measures in migraine and post-traumatic headaches. Pain 1999;79:235-242.
35. Asberg M, Nordstrom P, Traskman-Bendz L: Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci 1986;487:243-255.
36. Corruble E, Benyamina A, Bayle F, Falissard B, Hardy P: Understanding impulsivity in severe depression? A psychometrical contribution. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:829-833.
37. Alda M: Genetic factors and treatment of mood disorders. Bipol Disord 2001;3:318-324.
38. Meador KJ, Loring DW, Davis HC, Setli KD, Patel BR, Adams RJ: Cholinergic and serotonergic effects on P3 potential and recent memory. J Clin Exp Neuropsychol 1989;11:252-260.
39. Nutt DJ: The neuropharmacology of serotonin and noradrenaline in depression. Int Clin Psychopharmacol 2002;17(suppl 1):S1-12.
40. Stahl S: 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs? Psychopharmacol Bull 1994;30:39-43.
41. Yu Y W-Y, Chen TJ, Chen MC, Tsai SJ, Lee TW: Effect of age and global function score on schizophrenic P300 characteristics. Neuropsychobiology, in press.
42. Hirayasu Y, Samura M, Ohta H, Ogura C: Sex effects on rate of change of P300 latency with age. Clin Neurophysiol 2000;111:187-194.
43. Mulert C, Juckel G, Augustin H, Hegerl U: Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 2002;113:1566-1572.